Rituximab in combination with bendamustine or chlorambucil for the treatment of chronic lymphocytic leukemia: primary results from the randomised Phase IIIb MABLE study

Authors
Category Primary study
ConferenceXVI International Workshop on Chronic Lymphocytic Leukaemia, Sydney, Australia
Year 2015
This article has no abstract
Epistemonikos ID: 7a1e15a55dd59982a9638958e253f1307b6c55ab
First added on: Oct 13, 2018